Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,512 | 121,602 | 61,292 | 53,877 | 108,405 |
| Marketable Securities | 135,030 | 67,229 | 50,409 | 68,282 | 24,899 |
| TOTAL | $179,121 | $196,702 | $115,908 | $127,669 | $139,582 |
| Non-Current Assets | |||||
| PPE Net | 5,167 | 5,371 | 5,475 | 5,803 | 5,911 |
| Other Non-Current Assets | 21,731 | 21,862 | 21,764 | 1,549 | 929 |
| TOTAL | $26,898 | $27,233 | $27,239 | $7,352 | $6,840 |
| Total Assets | $206,019 | $223,935 | $143,147 | $135,021 | $146,422 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,055 | 2,921 | 1,724 | 1,198 | 1,956 |
| Accrued Expenses | 4,067 | 4,573 | 5,298 | 3,981 | 2,423 |
| TOTAL | $8,107 | $10,457 | $9,964 | $5,812 | $5,003 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 17,654 | 17,895 | 18,129 | 118 | 333 |
| TOTAL | $17,654 | $17,895 | $18,129 | $118 | $333 |
| Total Liabilities | $25,761 | $28,352 | $28,093 | $5,930 | $5,336 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,800 | 37,800 | 29,335 | 29,274 | 29,260 |
| Retained earnings | -228,366 | -210,900 | -194,341 | -178,440 | -164,972 |
| Other shareholders' equity | -45 | -72 | -147 | -128 | -5 |
| TOTAL | $180,258 | $195,583 | $115,054 | $129,091 | $141,086 |
| Total Liabilities And Equity | $206,019 | $223,935 | $143,147 | $135,021 | $146,422 |